How to treat Sjögren's syndrome

Elizabeth J. Price, Alan N. Baer

Research output: Contribution to journalReview articlepeer-review


SS is a chronic, autoimmune disease of unknown aetiology for which there is no known curative treatment. Although dryness of the eyes and mouth are the classically described features, patients often experience drying of other mucosal surfaces and systemic manifestations, including fatigue and arthralgia. There is an association with other autoimmune diseases, especially thyroid disease, coeliac disease and primary biliary cholangitis. Systemic features may affect up to 70% and include inflammatory arthritis, skin involvement, haematological abnormalities, neuropathies, interstitial lung disease and a 5-10% lifetime risk of B cell lymphoma. Treatment should aim to empower patients to manage their condition; conserve, replace and stimulate secretions; prevent damage; and suppress underlying systemic disease activity.

Original languageEnglish (US)
Pages (from-to)2574-2587
Number of pages14
JournalRheumatology (United Kingdom)
Issue number6
StatePublished - Jun 1 2021


  • Sjögren's
  • guideline
  • management
  • sicca

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Rheumatology


Dive into the research topics of 'How to treat Sjögren's syndrome'. Together they form a unique fingerprint.

Cite this